Cas:774-65-2 tert-butyl benzoate manufacturer & supplier

Chemical Name:tert-butyl benzoate

CAS.NO:774-65-2

Synonyms:Trimethylcarbinol benzoate;EINECS 212-267-2;1,1-Dimethylethyl benzoate;Benzoic acid tert-butyl ester;MFCD00048244;benzoic acid t-butyl ester;Benzoic acid 1,1-dimethylethyl ester;tert.-Butyl benzoate

Molecular Formula:C₁₁H₁₄O₂

Molecular Weight:178.22800

HS Code:2916310090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:54ºC / 1mmHg

Density:1 g/cm3

Index of Refraction:1.498

PSA:26.30000

Exact Mass:178.09900

LogP:2.64190

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Trimethylcarbinol benzoate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,tert.-Butyl benzoate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1,1-Dimethylethyl benzoate Use and application,Benzoic acid tert-butyl ester technical grade,usp/ep/jp grade.

Related News: The downstream industry of the pharmaceutical intermediate industry is mainly the production of APIs, and the relationship between APIs and preparations is in the upstream and downstream industry chain. The consumer demand for downstream preparations will directly affect the demand for APIs. tert-butyl benzoate manufacturer Jo Soden, Co-managing Director of Retrogenix, said ��We look forward to working with Resonant to deconvolute the targets for their antibodies. Resonant��s innovative platform is delivering functional therapeutic candidates at rapid pace and we welcome the opportunity to identify the specific, biologically-relevant targets which will help progress these leads towards promising new therapies for patients with cancer.�� tert-butyl benzoate supplier Therefore, the growth of the global pharmaceutical market has greatly affected the development of the entire intermediate and API industry. tert-butyl benzoate vendor Jo Soden, Co-managing Director of Retrogenix, said ��We look forward to working with Resonant to deconvolute the targets for their antibodies. Resonant��s innovative platform is delivering functional therapeutic candidates at rapid pace and we welcome the opportunity to identify the specific, biologically-relevant targets which will help progress these leads towards promising new therapies for patients with cancer.�� tert-butyl benzoate factory The downstream industry of the pharmaceutical intermediate industry is mainly the production of APIs, and the relationship between APIs and preparations is in the upstream and downstream industry chain. The consumer demand for downstream preparations will directly affect the demand for APIs.